Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Value of PGT-A when only one or two blastocysts are obtained: propensity-score matching and cost-effectiveness study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
Same author

Impact of cell loss after warming of human vitrified day 3 embryos on obstetric outcome in single frozen embryo transfers.

Journal of assisted reproduction and genetics·2022
Same author

Factors associated with embryo splitting and clinical outcome of monozygotic twins in pregnancies after IVF and ICSI.

Human reproduction open·2020
Same author

Thyroid hormones T3 and T4 regulate human luteinized granulosa cells, counteracting apoptosis and promoting cell survival.

Journal of endocrinological investigation·2020
Same author

Cost-utility analysis of 21-gene assay for node-positive early breast cancer.

Current oncology (Toronto, Ont.)·2019
Same author

Correction to: Contribution of cryopreservation to the cumulative live birth rate: a large multicentric cycle-based data analysis from the Italian National Registry.

Journal of assisted reproduction and genetics·2019
Same journal

Ovarian reserve markers in World Health Organization type 1 anovulatory disorders: a systematic review and meta-analysis.

Reproductive biomedicine online·2026
Same journal

Effect of embryo culture medium pH on live birth rate after IVF/ICSI: a double-blind, multicentre, randomized trial.

Reproductive biomedicine online·2026
Same journal

Response to: Clarifying Molecular Specificity and Outcome Definitions in Progestogen Route Meta-Analysis.

Reproductive biomedicine online·2026
Same journal

Polyendocrine metabolic ovarian syndrome and cardiometabolic profile in offspring: a propensity score matched cohort study.

Reproductive biomedicine online·2026
Same journal

Antinuclear antibodies in women with recurrent early pregnancy loss: prevalence and impact on subsequent pregnancy outcome.

Reproductive biomedicine online·2026
Same journal

Effect of adenomyosis on the cumulative live birth rate in oocyte donation cycles: a retrospective analysis.

Reproductive biomedicine online·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study.

F Olivennes1, C M Howles, A Borini

  • 1francois.olivennes@gmail.com

Reproductive Biomedicine Online
|February 5, 2009
PubMed
Summary
This summary is machine-generated.

The CONSORT dosing algorithm individualizes recombinant human FSH (r-hFSH) doses for assisted reproduction. This pilot study showed adequate oocyte yield and good pregnancy rates, suggesting algorithm adjustments could lower cancellation rates.

More Related Videos

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
06:40

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization

Published on: October 24, 2025

Related Experiment Videos

Last Updated: Jun 25, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
06:40

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization

Published on: October 24, 2025

Area of Science:

  • Reproductive Endocrinology
  • Assisted Reproductive Technologies

Background:

  • Individualized dosing of recombinant human FSH (r-hFSH) is crucial for optimizing outcomes in assisted reproduction.
  • The CONSORT algorithm aims to personalize r-hFSH doses based on patient characteristics.

Purpose of the Study:

  • To evaluate the efficacy and safety of the CONSORT dosing algorithm in normo-ovulatory women undergoing assisted reproduction.
  • To assess oocyte retrieval numbers and clinical pregnancy rates using algorithm-assigned r-hFSH doses.

Main Methods:

  • A prospective, uncontrolled, international pilot study involving 18 centers.
  • The CONSORT algorithm assigned follitropin alpha doses based on basal FSH, BMI, age, and antral follicle count.
  • Dose adjustments were primarily made to prevent ovarian hyperstimulation syndrome (OHSS).

Main Results:

  • Median oocyte retrieval was 9.0 across all groups.
  • Clinical pregnancy rates per cycle started ranged from 31.3% to 50.0% across different dose groups.
  • Higher than expected cancellation rates due to inadequate response were observed in the 75 IU group.

Conclusions:

  • The CONSORT algorithm demonstrated potential for achieving adequate oocyte yield and favorable pregnancy rates in assisted reproduction.
  • Further refinement of the algorithm may be necessary to reduce cancellation rates associated with suboptimal ovarian response.